School of Medicine
Showing 611-620 of 2,212 Results
-
Karleen Giannitrapani
Assistant Professor of Medicine (Primary Care and Population Health)
BioIn contrast to bounded teams with static membership, dynamic teaming reflects the common challenge of interdisciplinary healthcare teams with changing rosters. Such dynamic collaboration is critical to addressing multi-faceted problems and individualizing care. At present, off the shelf interventions to improve the way healthcare teams work - often assume static and bounded teams. Dr Giannitrapani intends to leverage design approaches to build a new kind of healthcare “teaming intervention,” which respects the nature of their constantly changing membership and more closely aligns with how healthcare teams actually collaborate. Their expertise includes organizational behavior, building interdisciplinary teams, implementation science, mixed methods-research, quality improvement, pain and palliative care research, and global health.
In addition to the Assistant Professor role in Division of Primary Care and Population Health at Stanford University School of Medicine they serve as the quality lead for the section of Palliative Medicine. They are also a Core Investigator at the Center for Innovation to Implementation (Ci2i) in the VA Palo Alto Health Care System and serve as PI or co-investigator on multiple ongoing studies representing over 25 million dollars of competitive government grant funding. They are also a Director of the VA Quality Improvement Resource Center (QuIRC) for Palliative Care, supporting Geriatrics and Extended Care programs for 170 Veterans Affairs facilities nationally. In QuIRC they lead a portfolio of projects on improving the processes that interdisciplinary teams can leverage to improve pain and symptom management among high-risk patients; a specific focus of their work is to bridge the gap of poor palliative care integration in the perioperative period.
They have given hundreds of presentations and have over 70 peer reviewed publications in high quality medical and health services delivery journals such as Medical Care, JAMA Surgery, the Journal of General Internal Medicine, the Journal of Pain and Symptom Management and Pain Medicine. They received a 5-year VA Career Development Award on building better teams across disciplines and was an American Academy of Hospice and Palliative Medicine Research Scholar for related work. -
Joshua Gillard
Postdoctoral Scholar, Cardiovascular Medicine
BioDr. Josh Gillard is a Canadian biomedical data scientist with experience in bioinformatics, machine learning, and immunology. After completing a BSc and a MSc in Experimental Medicine at McGill university, he relocated to the Netherlands for his PhD at Radboud University in Nijmegen. During his PhD, he gained experience analyzing and interpreting complex immunological data (bulk and single-cell transcriptomics, high-dimensional cytometry, proteomics data) derived from human observational or intervention studies (vaccination and experimental human infection) in order to discover molecular and cellular correlates of clinically important endpoints such as disease severity, symptom progression, and antibody responses. In 2022, Josh relocated to Stanford to join the Gaudilliere lab to develop and apply multi-omic data integration and machine learning techniques, establishing that early gestational immune dysregulation can predict preterm birth. Since 2024, in the Ashley lab, Josh is focused on the use of deep learning and transformer models to identify novel splice isoforms of hypertrophic cardiomyopathy using whole genome sequencing data.
-
Christophe Gimmler, MD, MFT
Clinical Assistant Professor (Affiliated), Primary Care and Population Health
BioChristophe Gimmler, MD, MFT, Assistant Clinical Professor of Medicine (Affiliated) at Stanford School of Medicine;
Staff Physician, Medical Service, VA Palo Alto Health Care System;
Licensed Marriage and Family Therapist.
_____________________________________________________________________________________________
After establishing and building the hospitalist and consult/liaison medicine service at the VA, Christophe now practices and teaches medical students and house staff in the primary care clinics there. He concurrently practices as a community psychotherapist and specializes in medical professionals. His central interest is the intersection of medicine and psychotherapy and, in particular, the application of psychological frameworks and skills to the practice of medicine, in addition to resiliency and burnout prevention. He developed the Medical Student Resiliency Skills Training program (MedReST) for the Stanford School of Medicine as well as the Resiliency Curriculum Series for the internal medicine residency program. He received as undergraduate degree in biology and psychology and an MD from the University of Virginia, completed his internal medicine residency at Stanford, and received a Master’s in Counseling Psychology from Sofia University.
Publications:
Foster Well-being Throughout the Career Trajectory: A Developmental Model of Physician Resilience Training:
Mayo Clinic Proceedings
Cordova MJ, Gimmler CE, Osterberg LG
2020; 95 (12):
Developing institutional infrastructure for physician wellness: qualitative Insights from VA physicians.
BMC Health Services Research
Schwartz, R., Shanafelt, T. D., Gimmler, C., Osterberg, L.
2020; 20 (1): 7 -
Alan M Glaseroff
Adjunct Professor, Medicine - Primary Care and Population Health
BioDr. Alan Glaseroff served as the Director of Workforce Transformation in Primary Care at Stanford from the fall of 2015 until mid-June of 2016, where he was responsible for training the teams for Primary Care 2.0, a radical redesign of primary care underway in 2016. He will be joining the faculty at Stanford's Clinical Excellence Research Center this summer, working with Dr. Arnie Milstein to help develop new models of care. He formerly served as Co-Director of Stanford Coordinated Care, a service for patients with complex chronic illness from 2011 to the end of 2015. Dr. Glaseroff, a member of the Innovation Brain Trust for the UniteHERE Health, currently serves as faculty for the Institute of Healthcare Improvement’s “Better Care, Lower Cost” collaborative and served as a a Clinical Advisor to the PBGH “Intensive Outpatient Care Program” CMMI Innovation Grant that completes in June 2015. He served on the NCQA Patient-Centered Medical Home Advisory Committee 2009-2010, and the “Let’s Get Healthy California” expert task force in 2012,. Dr. Glaseroff was named the California Family Physician of the Year for 2009.
Dr. Glaseroff’s interests focus on the intersection of the meaning of patient-centered team care, patient activation, and the key role of self-management within the context of chronic conditions.
The Coordinated Care clinic is an exclusive benefit for eligible members of the Stanford University, Stanford Health Care, SLAC and Lucile Packard Children’s Hospital community and their covered adult dependents with ongoing health conditions.
Please complete the Coordinated Care self-assessment to determine eligibility based on health condition(s) and health insurance: https://stanfordmedicine.qualtrics.com/SE/?SID=SV_2siBNrfJ8zmn3GB -
Jeffrey S. Glenn, M.D., Ph.D.
Joseph D. Grant Professor and Professor of Microbiology and Immunology
Current Research and Scholarly InterestsDr. Glenn's primary interest is in molecular virology, with a strong emphasis on translating this knowledge into novel antiviral therapies. Other interests include exploitation of hepatic stem cells, engineered human liver tissues, liver cancer, and new biodefense antiviral strategies.
-
Thomas Glynn
Adjunct Lecturer, Med/Stanford Prevention Research Center
BioBiosketch - Thomas J. Glynn, M.A., M.S., Ph.D. (psych.)
Dr. Glynn is, from 2014 to the present, Adjunct Lecturer, Stanford Prevention Research Center, Stanford University School of Medicine and Executive Team Member, Mayo Clinic Global Bridges Initiative. From 1998 to 2014, he was Director, Cancer Science and Trends and Director, International Cancer Control at the American Cancer Society (ACS). In these positions, he advised the ACS about emerging research and policy issues in cancer prevention and control, recommended cancer prevention and control research and policies, and participated in the development of an international cancer control program aimed at promoting cancer prevention-related research, advocacy, treatment, and policy change, particularly in middle- and low-income nations.
Prior to the ACS, Dr. Glynn was, from 1991 to 1994, Associate Director of the U.S. National Cancer Institute's (NCI) Cancer Control Science Program and, from 1991 to 1998, Chief of the NCI's Cancer Control Extramural Research Branch. There, he directed a national program of research aimed at reducing the incidence and prevalence of cancer, primarily through dietary change, tobacco use reduction, and adherence to cancer screening guidelines. From 1983 to 1991, he was Research Director for the NCI's Smoking, Tobacco, and Cancer Program and from 1978 to 1983, he was a Research Psychologist at the National Institute on Drug Abuse.
Dr. Glynn has published widely on cancer and tobacco use prevention and control, both in the scientific literature and for consumer, professional, and patient education and is co-developer of the 4A (now 5A) protocol for the treatment of tobacco dependence. In addition to his work at the ACS and NCI, he has served as a consultant on cancer control and tobacco issues to such groups as the National Academy of Sciences/Institute of Medicine, the National Research Council, the Robert Wood Johnson Foundation, the WHO, a variety of pharmaceutical organizations, and national, state and local governments.
He has also served as a Senior Scientific Reviewer for the U.S. Surgeon General's Reports on Tobacco and Health, as Director of the World Health Organization Study of Health, Economic, and Policy Implications of Tobacco Growth and Consumption in Developing Countries, and has been active in tobacco control programs in Eastern Europe, Central America, and India. He is a Fellow of the Society for Research on Nicotine and Tobacco and his awards include the U.S. National Institutes of Health Merit Award, the Polish Ministry of Health Service Award, the Guatemala National Council for Tobacco Prevention and Control Meritorious Service Award, the Society for Research on Nicotine and Tobacco John Slade Award, and the American Society of Preventive Oncology Joseph W. Cullen Memorial Award. -
Aparna Goel
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsDr. Goel is interested in studying the complications and management of patients with end-stage liver disease, including infections, bleeding and encephalopathy. As the waitlist for liver transplantation continues to grow, many patients develop consequences of decompensated liver disease. It is becoming increasingly important to improve our understanding and care of these complications in order to optimize the quality of life for this growing population of patients.
She is also particularly interested in the management of patients with autoimmune liver disease including autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis among others.
